During the past decade, Centre Hospitalier Intercommunal conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Intercommunal" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 5 trials, followed by "ARCAGY/ GINECO GROUP" with 3 trials sponsored, "Centre Hospitalier Universitaire de Nice" with 3 trials sponsored, "The Lymphoma Academic Research Organisation" with 3 trials sponsored and "Hospira, now a wholly owned subsidiary of Pfizer" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Intercommunal" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Intercommunal" are "Metastatic Colorectal Cancer" (2 trials), "Cardiac Arrest" (1 trials), "Chemotherapy-induced Anemia" (1 trials), "Chemotherapy-induced Febrile Neutropenia (FN)" (1 trials) and "Colonic Adenocarcinoma" (1 trials). Many other conditions were trialed in "Centre Hospitalier Intercommunal" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Intercommunal" are "Drug" (12 trials), "Other" (5 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "5Fluorouracil bolus" (1 trials), "5Fluorouracil continu" (1 trials), "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Intercommunal" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier Intercommunal". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centre Hospitalier Intercommunal, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Intercommunal, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".